SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Array Biopharma, Inc -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (272)10/21/2013 10:29:23 AM
From: scaram(o)uche  Respond to of 321
 
>> tweeting for ASH <<

AACR-NCI-EORTC, sorry.



To: scaram(o)uche who wrote (272)10/21/2013 9:05:39 PM
From: mcbio  Read Replies (1) | Respond to of 321
 
Yep, NVS is already running a MEK162+LEE011 combo trial in NRAS melanoma: clinicaltrials.gov .